Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PLRX compared with PMVP: revenue, margins and what each company keeps, and the suppliers and customers both name
PLRX
Pliant Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PMVP
PMV Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PLRX
Pliant Therapeutics, Inc.
vs
PMVP
PMV Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PLRX: latest quarter is a loss; flow not drawable. PMVP: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PLRX
1
NVS
Novartis
supplier
Shared
0
No shared counterparties.
Only PMVP
1
—
Foundation Medicine
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PLRX, solid
PMVP, dashed
PLRX
Pliant Therapeutics, Inc.
Change
0.85
▼
−1.58%
· post 0.85
Mkt cap
$53.2M
Revenue
$248,000
Q2 FY23
PMVP
PMV Pharmaceuticals, Inc.
Change
1.31
▼
−3.07%
· post 1.31
Closed
Oct 30 '26
Mkt cap
$70.0M
Revenue
—
vs
Compare
Closed
Oct 30 '26
PLRX
Pliant Therapeutics, Inc.
vs
PMVP
PMV Pharmaceuticals, Inc.
0.85
▼
−1.58%
post 0.85
Price
1.31
▼
−3.07%
post 1.31
$53.2M
Mkt cap
$70.0M
Q2 FY23
$248,000
Revenue
—
Change
Change
PLRX
0.85
▼
−1.58%
vs
PMVP
1.31
▼
−3.07%
Closed
Oct 30 '26